Biosergen publishes interim report for first quarter 2022
Tuesday, May 31, 2022: Biosergen AB (“Biosergen” or the “Company”) thereby publishes the interim report for the firdst quarter 2022. The interim report is available as an attached document and on the company website (www.biosergen.net)Summary of the Interim Report for Q1 2022 Amounts in SEK '000 Q1 2022 Q1 2021 Year 2021Consolidated group revenue 1,317 0 11,570Consolidated group loss before depreciation -5,018 -8,305 -34,077Consolidated group loss before net financials - 5,018 -8,305 -34,077Consolidated